Compare GAIA & ASRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GAIA | ASRT |
|---|---|---|
| Founded | 1988 | 1995 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Movies/Entertainment | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 70.9M | 76.0M |
| IPO Year | 1999 | 2004 |
| Metric | GAIA | ASRT |
|---|---|---|
| Price | $2.41 | $23.43 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 1 | 2 |
| Target Price | $6.50 | ★ $18.00 |
| AVG Volume (30 Days) | 72.2K | ★ 418.0K |
| Earning Date | 05-04-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 18.18 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $4,500,000.00 | ★ $118,713,000.00 |
| Revenue This Year | $13.07 | N/A |
| Revenue Next Year | $12.04 | $12.85 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 12.50 | N/A |
| 52 Week Low | $2.30 | $0.60 |
| 52 Week High | $6.39 | $23.46 |
| Indicator | GAIA | ASRT |
|---|---|---|
| Relative Strength Index (RSI) | 40.58 | 87.21 |
| Support Level | $2.37 | $0.70 |
| Resistance Level | $3.41 | N/A |
| Average True Range (ATR) | 0.19 | 0.18 |
| MACD | -0.02 | 0.02 |
| Stochastic Oscillator | 11.73 | 98.12 |
Gaia Inc is a video streaming service and community that provides curated conscious media in primary channels; Seeking Truth provides new and enlightening perspectives for today's changing world; Transformation provides a wealth of content in the niche areas of spiritual growth, personal development, and expanded consciousness; Alternative Healing channel features content focused on food and nutrition, holistic healing, alternative and integrative medicines, and longevity, and Yoga. The company operates in a single reporting segment. Its revenues is derived from subscription fees for services related to streaming content to the members. Geographically, it derives a majority of its revenue from the United States and also has an International presence.
Assertio Holdings Inc is a pharmaceutical company. It is engaged in providing solutions to advance patient care in the areas of neurology, orphan and specialty medicines. The company markets three FDA-approved products for various neurological conditions including Gralise, tablets for the management of postherpetic neuralgia; CAMBIA, for acute treatment of migraine attacks with or without aura in adults of age or older and Zipsor, liquid-filled capsules for relief of mild to moderate pain.